Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Genetic Predisposition: full-pipeline trial registry
12 of 15 indexed Genetic Predisposition trials are currently recruiting.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 12 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Genetic Predisposition: 15 US clinical trials tracked, 12 recruiting.
Genetic Predisposition is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 2 of these trials.
Enrollment posture brief
Registry condition genetic-predisposition
OPEN 12 | RECR 80% | LATE 1 | EARLY 1 | RANK #1140 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Ablation (80% recruiting · 5 trials)
Genetic Predisposition lists 12 open slots (80% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Genetic Predisposition on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Genetic Predisposition is recruiting above its size-band peers.
12 of 15 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Genetic Predisposition trials is spread across many organizations.
Dana-Farber Cancer Institute accounts for 2 of 15 trials (13.3%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Genetic Predisposition enrolment sits around 400 participants.
Median target enrolment is 400 among the 15 trials that report a genuine target (sentinel values excluded). 4 of those (26.7%) plan for fewer than 100 participants.
-
Genetic Predisposition splits between interventional and observational designs.
8 interventional and 7 observational studies make up this index (53.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Pancreatic Cancer Early Detection Consortium
Arbor Research Collaborative for Health
NCT04970056
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Columbia University
NCT05929976
Vascular Disease Discovery Protocol
National Heart, Lung, and Blood Institute (NHLBI)
NCT03538639
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
NCT06377033
APOL1 Genetic Testing in African Americans
St. Louis University
NCT05656261
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Dana-Farber Cancer Institute
NCT05587439
Prostate Tissue BioBank
Abramson Cancer Center at Penn Medicine
NCT06659614
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Massachusetts General Hospital
NCT06003153
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
St. Jude Children's Research Hospital
NCT05849155
Genetic Information Assistant in Telegenetics
University of Virginia
NCT06089421
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
Children's Mercy Hospital Kansas City
NCT06554288
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Dana-Farber Cancer Institute
NCT05759143
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Abramson Cancer Center at Penn Medicine
NCT04774445
Overcoming Barriers to Accessing Genetic Medicine
Boston Children's Hospital
NCT05064241
Early Detection of GEnetic Risk (EDGE)
University of Washington
NCT04746794
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Genetic Predisposition records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Genetic Predisposition trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Genetic Predisposition page
15 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Genetic Predisposition trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Genetic Predisposition trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Genetic Predisposition condition card totals 15 registered trials; most-linked intervention Population-level screening; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.